Results 161 to 170 of about 15,976 (198)

Myopic choroidal neovascularization: natural course and treatment

Current Opinion in Ophthalmology, 2004
Choroidal neovascularization (CNV) is the most common vision-threatening complication of high myopia. Myopic CNV has recently attracted a lot of attention, mainly because of a variety of newly developed treatments. To evaluate the efficacy of these new treatments against myopic CNV, we need to know more precisely the natural course of myopic CNV.
Kyoko, Ohno-Matsui, Takeshi, Yoshida
openaire   +2 more sources

Myopic Choroidal Neovascularization

2006
Pathological myopia is synonymous with high myopia and generally refers to a condition in which individuals have greater than 6 to 8 diopters of myopia or an axial length greater than 26 to 27 mm Pathological myopia is a major cause of legal blindness in many developed countries (2, 3, 4), affecting 27 to 33% of all myopic eyes, which corresponds to a ...
Kyoko Ohno-Matsui, Takashi Tokoro
openaire   +1 more source

INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION

Retina, 2010
The purpose of this study was to evaluate the safety and efficacy of intravitreal ranibizumab after 12 months in the treatment of choroidal neovascularization secondary to pathologic myopia.This was a prospective, multicenter, consecutive, nonrandomized, interventional case series.
Silva, RM, Ruiz-Moreno, JM, Rosa, P, Carneiro, A, Nascimento, J, Rito, LF, Cachulo, ML, Carvalheira, F, Murta, JN   +8 more
openaire   +3 more sources

Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology, 2004
Photodynamic therapy is a relatively new modality for the treatment of subfoveal choroidal neovascularization (CNV). An unusual response to verteporfin therapy of myopic CNVs is reported.Out of 187 CNVs secondary to pathologic myopia treated with photodynamic therapy, three eyes manifested two separate foci of CNV before treatment.
Lanzetta P, Parodi MB, Ambesi Impiombato M, Ravalico G, BANDELLO , FRANCESCO   +4 more
openaire   +3 more sources

Choroidal neovascularization in myopic eyes after photorefractive keratectomy

Journal of Cataract and Refractive Surgery, 2000
To evaluate the incidence, characteristics, and results of treatment of choroidal neovascularization (CNV) in myopic eyes corrected by photorefractive keratectomy (PRK).University Miguel Hernández, Instituto Oftalmológico de Alicante, Alicante, Spain.This study was of the incidence of CNV in 5936 consecutive eyes that had PRK for the correction of ...
J M, Ruiz-Moreno, A, Artola, M J, Ayala, P, Claramonte, J L, Alió   +4 more
openaire   +2 more sources

PREDICTING LESION SHRINKAGE IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM FEATURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Retina, 2022
Supplemental Digital Content is Available in the Text. The response to anti–vascular endothelial growth factor therapy for myopic choroidal neovascularization can be predicted by optical coherence tomography angiography.
Jing Liu, Shuang Song, Xiaobing Yu
semanticscholar   +1 more source

MACULAR CHOROIDAL VOLUME VARIATIONS IN HIGHLY MYOPIC EYES WITH MYOPIC TRACTION MACULOPATHY AND CHOROIDAL NEOVASCULARIZATION

Retina, 2014
To compare the choroidal volume (CV) between emmetropic and highly myopic eyes, and to assess if the presence of myopic fundus abnormalities, myopic traction maculopathy, or choroidal neovascularization affects the CV.We retrospectively reviewed imaging studies of 98 eyes of 98 patients who underwent CV measurement on optical coherence tomography.
G. Barteselli, S. N. Lee, S. El Emam, H. Hou, F. Ma, J. Chhablani, L. Conner, L. Cheng, D. U. Bartsch, W. R. Freeman   +9 more
openaire   +2 more sources

Myopic Choroidal Neovascularization: Diagnosis and Treatment Update

Current Ophthalmology Reports, 2019
To review the diagnosis and treatment of myopic choroidal neovascularization. Imaging tests currently available and the advantages of each modality for detecting choroidal neovascularization signs are discussed. The management options and the outcomes of different treatment options are also reviewed.
Mariana R. Thorell, Raquel Goldhardt
openaire   +1 more source

[Therapy of myopic choroidal neovascularization].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2013
Recently published studies have shown that myopic choroidal neovascularization (mCNV) is efficiently treated by anti-vascular endothelial growth factor (VEGF) drugs. Within a prospective executive study, photodynamic therapy failed to prove a significant difference over the duration of 2 years.
B, Voykov, F, Ziemssen, K U, Bartz-Schmidt   +2 more
openaire   +1 more source

Anti‐vascular endothelial growth factor for myopic choroidal neovascularization

Clinical & Experimental Ophthalmology, 2012
AbstractMyopic choroidal neovascularization (CNV) is a vision‐threatening complication in the eyes with pathological myopia, which is particularly prevalent among young and middle‐aged Asians globally. To date, the verteporfin in photodynamic therapy study is the only randomized‐controlled study in treatment of subfoveal myopic CNV.
Danny S, Ng, Alvin K H, Kwok, Clement W, Chan   +2 more
openaire   +2 more sources